ABSTRACT
The cancerogenic activity of the dispirotripiperasinium derivatives prospidine and spirobromine was tested in concurrent use with sodium nitrite. The drugs were intragastrically administered once a week. It was combined with sodium nitrite, 35 mg/kg, to non-inbred rats of both sex during 24 months. A morphological study revealed no statistically significant reduction of latency and no increase in the incidence of tumors in laboratory animals. No cancerogenic effect of sodium nitrite was found.
Subject(s)
Carcinogens/toxicity , Cocarcinogenesis , Piperazines/toxicity , Sodium Nitrite/toxicity , Spiro Compounds/toxicity , Administration, Oral , Animals , Antineoplastic Agents/administration & dosage , Antineoplastic Agents/toxicity , Carcinogens/administration & dosage , Chi-Square Distribution , Female , Incidence , Male , Neoplasms, Experimental/chemically induced , Neoplasms, Experimental/epidemiology , Piperazines/administration & dosage , Prospidium/administration & dosage , Prospidium/toxicity , Rats , Sodium Nitrite/administration & dosage , Spiro Compounds/administration & dosageSubject(s)
Hypothyroidism/blood , Thyroid Diseases/diagnosis , Triiodothyronine/blood , Animals , Male , Rats , Thyroid Diseases/bloodABSTRACT
Administration of piracetam to infantile rats in a daily dose of 100 mg/kg for 10 days caused acceleration of sexual maturation of females and a slight delay of maturation of males. Antenatal administration of the same dose of piracetam exerted a depressive action on the development of the organs of the reproductive system in males from the offspring with a simultaneous increase in the pituitary gonadotropic activity.